A new study published in The New England Journal of Medicine today showed that patients with advanced melanoma may experience significantly longer overall survival when
An on-going clinical trial suggests that gene therapy is effective in stopping the progression of Cerebral Adrenoleukodystrophy Cerebral Adrenoleukodystrophy (CALD) is a severe and potentially
Verzenio (also known as abemaciclib) is a drug developed by Eli Lilly to treat HR-positive, HER2-negative patients with advanced or metastatic breast cancer who are
Researchers at The St. Michael’s Hospital and University of Toronto conducted a meta-analysis of 142 previous clinical trials to compare the safety and effectiveness of
The kidney makes a hormone called “erythropoietin (EPO)”, which triggers the production of red blood cells. The production of EPO is reduced in patients with
Warfarin (also known as Coumadin) is a blood thinner frequently prescribed to individuals vulnerable to stroke, and to patients having joint replacement surgery. However, determining
“Chronic Traumatic Encephalopathy (CTE)” is a progressive brain disease associated with repetitive trauma to the head. War veterans and athletes in contact sports such as
On August 28, the Food and Drug Administration (FDA) expanded its approval of the estrogen-blocking drug fulvestrant (Faslodex®) for some women with advanced breast cancer. The new
